EAM
MDGL icon

EULAV Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

EULAV Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.7M Hold
49,000
– – 0.82% 42
2025
Q4 		$28.5M Sell
49,000
-2,000
-4% -$1.02M 0.76% 44
2025
Q3 		$23.4M Buy
51,000
+20,000
+65% +$7.46M 0.54% 64
2025
Q2 		$9.38M Buy
31,000
+21,000
+210% +$6.26M 0.22% 102
2025
Q1 		$3.31M Hold
10,000
– – 0.08% 147
2024
Q4 		$3.09M Hold
10,000
– – 0.07% 149
2024
Q3 		$2.12M Hold
10,000
– – 0.05% 158
2024
Q2 		$2.8M Sell
10,000
-1,000
-9% -$238K 0.08% 152
2024
Q1 		$2.94M Sell
11,000
-2,000
-15% -$471K 0.08% 154
2023
Q4 		$3.01M Buy
+13,000
New +$2.27M 0.09% 150

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return